RT @DrRPalmquist: Targeting EGFR and uPAR on human rhabdomyosarcoma, osteosarcoma, and ovarian adenocarcinoma with a bispecific ligand-dire…
RT @DrRPalmquist: Targeting EGFR and uPAR on human rhabdomyosarcoma, osteosarcoma, and ovarian adenocarcinoma with a bispecific ligand-dire…
Targeting EGFR and uPAR on human rhabdomyosarcoma, osteosarcoma, and ovarian adenocarcinoma with a bispecific ligand-directed toxin. - PubMed - NCBI #ACVIM2019 presenting #dog #research #hemangiosarcoma #eBAT #sarcoma https://t.co/n2nMgGjWsX
This technical abstract reports that a drug targeting two types of receptors on cancer cells showed effectiveness in certain sarcoma cell lines.... https://t.co/8sJlp6BjSS
Targeting EGFR and uPAR on human #rhabdomyosarcoma, #osteosarcoma, and #ovarian adenocarcinoma. @DovePress https://t.co/OIlInEZyZz #sarcoma #gyncsm #ayacsm #scmsm